This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
CrowdStrike (CRWD) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for CrowdStrike (CRWD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CRWDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in PulteGroup (PHM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PulteGroup (PHM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PHMNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Cisco (CSCO): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cisco (CSCO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CSCOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Micron (MU) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Micron (MU) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
MUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is ACM Research (ACMR) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for ACM Research (ACMR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ACMRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Arista Networks (ANET) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Arista Networks (ANET). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ANETPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in JD.com (JD) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), JD.com (JD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
JDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Robinhood Markets (HOOD) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Robinhood Markets (HOOD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HOODPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Celestica (CLS) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Celestica (CLS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CLSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Itron (ITRI) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Itron (ITRI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ITRINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in AST SpaceMobile (ASTS) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AST SpaceMobile (ASTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ASTSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in CRH (CRH) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), CRH (CRH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CRHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See AppFolio (APPF) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), AppFolio (APPF) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
APPFPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Trip.com (TCOM): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Trip.com (TCOM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
TCOMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Dick's (DKS) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Dick's (DKS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
DKSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Sensus Healthcare (SRTS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SRTSPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Honeywell International (HON) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Honeywell International (HON) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
HONNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Sweetgreen (SG): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Sweetgreen (SG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Humacyte, Inc. (HUMA): Should You Buy?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Humacyte, Inc. (HUMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
HUMAPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
BigBear.ai (BBAI) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in BigBear.ai (BBAI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
BBAINegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Constellation Energy Corporation (CEG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Constellation Energy Corporation (CEG). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CEGPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Teekay Tankers (TNK) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Teekay Tankers (TNK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TNKPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is AudioEye (AEYE) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in AudioEye (AEYE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
AEYEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Okta (OKTA) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Okta (OKTA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
OKTANegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Cipher Mining (CIFR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cipher Mining (CIFR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CIFRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth